FDA Issues Final Rule and FAQ Regarding Direct-to-Consumer Drug Advertising | Faegre Drinker Biddle & Reath LLP

In a stride toward transparency and heightened consumer awareness, the Food and Drug Administration (FDA) has issued a final rule, dated November 21, 2023, to amend its regulations...

Related Keywords

,Faegre Drinker Biddle Reath ,Promotional Labeling Branch Of The Center ,Drug Administration Amendments ,Drug Administration ,Office Of Prescription Drug Promotion ,Faegre Drinker Biddle ,Drug Administration Amendments Act ,Final Rule ,Prescription Drug Promotion ,Drug Evaluation ,Promotional Labeling Branch ,Biologics Evaluation ,Providing Regulatory Submissions ,Non Electronic Format ,Promotional Labeling ,Advertising Materials ,Human Prescription Drugs ,Potential Industry ,